The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow

Journal of Clinical Investigation

Volumn 101, Issue 9, 1998, Pages 2017-2024

  Kitayama, Joji ^a   Mackay, Charles R ^b   Ponath, Paul D ^b   Springer, Timothy A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Chemokine receptor; Endothelium; Eosinophils; Eotaxin; Very late antigen 4

Indexed keywords

CHEMOKINE RECEPTOR; EOTAXIN; VERY LATE ACTIVATION ANTIGEN;

ARTICLE; EOSINOPHIL; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; SHEAR STRESS; VASCULAR ENDOTHELIUM;

EID: 0032080410     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2688     Document Type: Article

References (66)

1. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multi-step paradigm. Cell. 76:301-314.
2. Butcher, E.C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 67:1033-1036.
3. Lawrence, M.B., and T.A. Springer. 1991. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 65:859-873.
4. Honda, S., J.J. Campbell, D.P. Andrew, B. Engelhardt, B.A. Butcher, R.A. Warnock, R.D. Ye, and E.C. Butcher. 1994. Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor. J. Immnnol. 152:4026-4035.
5. McLellan, A.D., R.V. Sorg, L.A. Williams, and D.N.J. Hart. 1996. Human dendritic cells activate T lymphocytes via a CD40 ligand-dependent pathway. Eur. J. Immunol. 26:1204-1210.
6. Rot, A. 1992. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol. Today. 13:291-294.
7. Tanaka, Y., D.H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature. 361:79-82.
8. Gleich, G.J., and C.R. Adolphson. 1986. The eosinophilic leukocyte: structure and function. Adv. Immunol. 39:177-253.
9. Bousquet, J., P. Chanez, J.Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F.-B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
10. Kameyoshi, Y., A. Dörschner, A.I. Mallet, E. Christophers, and J.-M. Schröder. 1992. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176:587-592.
11. Rot, A., M. Krieger, T. Brunner, S.C. Bischoff, T.J. Schall, and C.A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176:1489-1495.
12. Ebisawa, M., T. Yamada, C. Bickel, D. Klunk, and R.P. Schleimer. 1994. Eosinophil transendothelial migration induced by cytokines: III. Effect of the chemokine RANTES. J. Immunol. 153:2153-2160.
13. Noso, N., P. Proost, J. Van Damme, and J.-M. Schröder. 1994. Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem. Biophys. Res. Commun. 200:1470-1476.
14. Dahinden, C.A., T. Geiser, T. Brunner, V. von Tscharner, D. Caput, P. Ferrara, A. Minty, and M. Baggiolini. 1994. Monocyte chemotactic protein 3 is a most effective basophil-and eosinophil-activating chemokine. J. Exp. Med. 179:751-756.
15. Uguccioni, M., P. Loetscher, U. Forssmann, B. Dewald, H. Li, S.H. Lima, Y. Li, B. Kreider, G. Garotta, M. Thelen, and M. Baggiolini. 1996. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J. Exp. Med. 183:2379-2384.
16. Rothenberg, M.E., A.D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA. 92:8960-8964.
17. Ponath, P.D., S. Qin, D.J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J.-A. Gonzalo, W. Newman, et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604-612.
18. 2+-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood. 88:3195-3199.
19. Elsner, J., R. Hochstetter, D. Kimmig, and A. Kapp. 1996. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur. J. Immunol. 26:1919-1925.
20. Forssmann, U., M. Uguccioni, P. Loetscher, C.A. Dahinden, H. Langen, M. Thelen, and M. Baggiolini. 1997. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. 185:2171-2176.
21. Weber, C., J. Kitayama, and T.A. Springer. 1996. Differential regulation of β1-and β2-integrin avidity by chemoattractants in eosinophils. Proc. Natl. Acad. Sci. USA. 93:10939-10944.
22. Kita, H., and G.J. Gleich. 1996. Chemokines active on eosinophils: potential roles in allergic inflammation. J. Exp. Med. 183:2421-2426.
23. Mackay, C.R. 1996. Chemokine receptors and T cell chemotaxis. J. Exp. Med. 184:799-802.
24. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55: 97-179.
25. Baggiolini, M., and C.A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunol. Today. 15:127-133.
26. Ponath, P.D., S. Qin, T.W. Post, J. Wang, L. Wu, N.P. Gerard, W. Newman, C. Gerard, and C.R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437-2448.
27. Daugherty, B.L., S.J. Siciliano, J.A. DeMartino, L. Malkowitz, A. Sirotina, and M.S. Springer. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183:2349-2354.
28. Heath, H., S. Qin, P. Rao, L. Wu, G. LaRosa, N. Kassam, P.D. Ponath, and C.R. Mackay. 1997. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:178-184.
29. Wu, L., N. Ruffing, X. Shi, W. Newman, D. Soler, C.R. Mackay, and S. Qin. 1996. Discrete steps in binding and signaling of interleukin-8 with its receptor. J. Biol. Chem. 271:31202-31209.
30. Sanchez-Madrid, F., J. Nagy, E. Robbins, P. Simon, and T.A. Springer. 1983. A human leukocyte differentiation antigen family with distinct alpha subunits and a common beta subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p 150,95 molecule. J. Exp. Med. 158:1785-1803.
31. Marlin, S.D., D.E. Staunton, T.A. Springer, C. Stratowa, W. Sommergruber, and V. Merluzzi. 1990. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature. 344:70-72.
32. Pepinsky, B., C. Hession, L.-L. Chen, P. Moy, L. Burkly, A. Jakubowski, E.P. Chow, C. Benjamin, G. Chi-Rosso, S. Luhowskyj, and R. Lobb. 1992. Structure/function studies on vascular cell adhesion molecule-1. J. Biol. Chem. 267:17820-17826.
33. Hansel, T.T., J.D. Pound, D. Pilling, G.D. Kitas, M. Salmon, T.A. Gentle, S.S. Lee, and R.A. Thompson. 1989. Purification of human blood eosinophils by negative selection using immunomagnetic beads. J. Immunol. Methods. 122:97-103.
34. Gimbrone, M.A., Jr. 1976. Culture of vascular endothelium. Prog. Hemostasis Thromb. 3:1-28.
35. Roth, S.J., M.W. Carr, S.S. Rose, and T.A. Springer. 1995. Characterization of transendothelial chemotaxis of T lymphocytes. J. Immunol. Methods. 100:97-116.
36. Jones, D.A., O. Abbassi, L.V. McIntire, R.P. McEver, and C.W. Smith. 1993. P-selectin mediates neutrophil rolling on histamine-stimulated endotheual cells. Biophys. J. 65:1560-1569.
37. Lawrence, M.B., and T.A. Springer. 1993. Neutrophils roll on E-selectin. J. Immunol. 151:6338-6346.
38. Weller, P.F., T.H. Rand, S.E. Goelz, G. Chi-Rosso, and R.R. Lobb. 1991. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 88:7430-7433.
39. Dobrina, A., R. Menegazzi, T.M. Carlos, E. Nardon, R. Cramer, T. Zacchi, J.M. Harlan, and P. Patriarca. 1991. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced endothelial ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J. Clin. Invest. 88:20-26.
40. Bochner, B.S., F.W. Luscinskas, M.A. Gimbrone, Jr., W. Newman, S.A. Sterbinsky, C.P. Derse-Anthony, D. Klunk, and R.P. Schleimer. 1991. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J. Exp. Med. 173:1553-1556.
41. 1 (very late antigen-4) dependent. J. Immunol. 146:3419-3423.
42. Kitayama, J., M.W. Carr, S.J. Roth, J. Buccola, and T.A. Springer, 1997. Contrasting responses to multiple chemotactic stimuli in transendothelial migration. J. Immunol. 158:2340-2349.
43. Pons, F., A.G. Rossi, K.E. Norman, T.J. Williams, and S. Nourshargh. 1993. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: affect of the novel long-acting PAF antagonist, UK-74,505. Br. J. Pharmacol. 109:234-242.
44. Sanz, M.J., V.B. Weg, D.T. Walsh, T.J. Williams, and S. Nourshargh. 1994. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin. Br. J. Pharmacol. 113:513-521.
45. Marfaing-Koka, A., O. Devergne, G. Gorgone, A. Portier, T.J. Schall, P. Galanaud, and D. Emilie. 1995. Regulation of the production of the RANTES chemokine by endothelial cells. J. Immunol. 154:1870-1878.
46. Baggiolini, M., A. Walz, and S.L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1045-1049.
47. Detmers, P.A., D.E. Powell, A. Walz, I. Clark-Lewis, M. Baggiolini, and Z.A. Cohn. 1991. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J. Immunol. 147: 4211-4217.
48. Westlin, W.F., J.-M. Kiely, and M.A. Gimbrone. 1992. Interleukin-8 induces changes in human neutrophil actin conformation and distribution: relationship to inhibition of adhesion to cytokine-activated endothelium. J. Leukocyte Biol. 52:43-51.
49. Berlin, C., R.F. Bargatze, U.H. von Andrian, M.C. Szabo, S.R. Hasslen, R.D. Nelson, E.L. Berg, S.L. Erlandsen, and E.C. Butcher. 1995. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 80: 413-122.
50. Alon, R., P.D. Kassner, M.W. Carr, E.B. Finger, M.E. Hemler, and T.A. Springer. 1995. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128:1243-1253.
51. 2-integrins. J. Cell Biol. 125: 1417-1427.
52. + T lymphocytes on tumor necrosis factor α-activated vascular endothelium under flow. J. Exp. Med. 181:1179-1186.
53. Camussi, G., F. Bussolino, G. Salvidio, and C. Baglioni. 1987. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J. Exp. Med. 166:1390-1404.
54. Honda, Z., M. Nakamura, I. Miki, M. Minami, T. Watanabe, Y. Seyama. H. Okado, H. Toh, K. Ito, T. Miyamoto, and T. Shimizu. 1991. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 349:342-346.
55. Zimmerman, G.A., T.M. McIntyre, M. Mehra, and S.M. Prescott. 1990. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J. Cell Biol. 110:524-540.
56. Lorant, D.E., K.D. Patel, T.M. McIntyre, R.P. McEver, S.M. Prescott, and G.A. Zimmerman. 1991. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J. Cell Biol. 115:223-234.
57. Macconi, D., M. Foppolo, S. Paris, M. Noris, S. Aiello, G. Remuzzi, and A. Remuzzi. 1445. PAF mediates neutrophil adhesion to thrombin or TNF-stimulated endothelial cells under shear stress. Am. J. Physiol. 269:C42-C47.
58. Kimani, G., M.G. Tonnesen, and P.M. Henson. 1988. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. J. Immunol. 140:3161-3166.
59. 7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin. Immunology. 89:112-114.
60. 2) on human neutrophils. J. Exp. Med. 173:1443-1500.
61. Kuijpers, T.W., B.C. Hakkert, M. Hoogerwerf, J.F. M. Leeuwenberg, and D. Roos. 1991. Role of endothelial leukocyte adhesion molecule-1 and platelet-activating factor in neutrophil adherence to IL-1-prestimulated endothelial cells. Endothelial leukocyte adhesion molecule-1-mediated CD18 activation. J. Immunol. 147:1361-1376.
62. Kuijpers, T.W., M. Hoogerwerf, L.J.W. van der Laan, G. Nagel, C.E. Van Der Schoot, F. Grunert, and D. Roos. 1992. CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. J. Cell Biol. 118:457-166.
63. 2-imegrin. J. Immunol. 155:1502-1514.
64. Gopalan, P.K., C.W. Smith, H. Lu, E.L. Berg, L.V. McIntire, and S.I. Simon. 1997. Neutrophil CD18-dependent arrest on intercellular adhesion molecule 1 (ICAM-1) in shear flow can be activated through L-selectin. J. Immunol. 158:367-375.
65. Sriramarao, P., C.R. Norton, P. Borgstrom, R.G. DiScipio, B.A. Wolitzky, and D.H. Broide. 1996. E-selectin preferentially supports neutrophil but not eosinophil rolling under conditions of flow in vitro and in vivo. J. Immunol. 157:4672-1680.
66. Henriques, G.M.O., J.M. Miolta, R.S.B. Cordeiro, B.A. Wolitzky, S.T. Woolley, and P.G. Hellewell. 1996. Selectins mediate eosinophil recruitment in vivo: a comparison with their role in neutrophil influx. Blood. 87:5297-5304.